Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1350.20

11.70 (0.87%)

< Home < Back

USFDA completes inspection at Dr. Reddy's Srikakulum Plant

Date: 16-01-2019

Untited state Food and Drug Administration (USFDA) has completed audit of Dr. Reddy's Laboratories’ Formulations Srikakulum Plant (SEZ) Unit I in the state of Andhra Pradesh. The company has been issued a Form 483 with 4 observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.